{
    "Rank": 614,
    "Study": {
        "ProtocolSection": {
            "IdentificationModule": {
                "NCTId": "NCT03467308",
                "OrgStudyIdInfo": {
                    "OrgStudyId": "CRC18"
                },
                "Organization": {
                    "OrgFullName": "Assiut University",
                    "OrgClass": "OTHER"
                },
                "BriefTitle": "Signaling Pathways Targeting Colorectal Cancer in Egypt",
                "OfficialTitle": "Identification of New Signaling Pathways Targeting Colorectal Cancer in Egyptian Patients"
            },
            "StatusModule": {
                "StatusVerifiedDate": "May 2020",
                "OverallStatus": "Completed",
                "ExpandedAccessInfo": {
                    "HasExpandedAccess": "No"
                },
                "StartDateStruct": {
                    "StartDate": "March 1, 2018",
                    "StartDateType": "Actual"
                },
                "PrimaryCompletionDateStruct": {
                    "PrimaryCompletionDate": "January 1, 2020",
                    "PrimaryCompletionDateType": "Actual"
                },
                "CompletionDateStruct": {
                    "CompletionDate": "April 1, 2020",
                    "CompletionDateType": "Actual"
                },
                "StudyFirstSubmitDate": "February 20, 2018",
                "StudyFirstSubmitQCDate": "March 9, 2018",
                "StudyFirstPostDateStruct": {
                    "StudyFirstPostDate": "March 16, 2018",
                    "StudyFirstPostDateType": "Actual"
                },
                "LastUpdateSubmitDate": "May 7, 2020",
                "LastUpdatePostDateStruct": {
                    "LastUpdatePostDate": "May 11, 2020",
                    "LastUpdatePostDateType": "Actual"
                }
            },
            "SponsorCollaboratorsModule": {
                "ResponsibleParty": {
                    "ResponsiblePartyType": "Principal Investigator",
                    "ResponsiblePartyInvestigatorFullName": "Asmaa Alaaeldeen Kamal Thabet",
                    "ResponsiblePartyInvestigatorTitle": "Principal Investigator",
                    "ResponsiblePartyInvestigatorAffiliation": "Assiut University"
                },
                "LeadSponsor": {
                    "LeadSponsorName": "Assiut University",
                    "LeadSponsorClass": "OTHER"
                }
            },
            "OversightModule": {
                "OversightHasDMC": "No",
                "IsFDARegulatedDrug": "No",
                "IsFDARegulatedDevice": "No"
            },
            "DescriptionModule": {
                "BriefSummary": "Colorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. In Egypt, CRC constitutes 4.2% of all cancers with median age is 50 years old.",
                "DetailedDescription": "The TP53-induced glycolysis and apoptosis regulator (TIGAR) is a transcriptional target of p53. TIGAR functions as a fructose-2,6-bisphosphatase, decreasing the flux through the main glycolytic pathway. Consequently, glucose metabolism diverted into the pentose phosphate pathway (PPP). This results in TIGAR-mediated increase in cellular NADPH production, which contributes to the scavenging of ROS by reduced glutathione and thus a lower sensitivity of cells to oxidative stress-associated apoptosis. PPP also produce ribose phosphate for DNA synthesis and repair that play a role in tumor development and cell survival in tumor microenvironment. A high expression level of TIGAR was observed in cancers such as breast cancer, hepatocellular carcinoma, intestinal cancer, and glioblastoma. These studies suggested that TIGAR may act as an oncogene that support cancer progression.\n\nThe tripartite motif containing 59 (TRIM) proteins have been implicated in many biological processes including cell differentiation, apoptosis, transcriptional regulation, and signaling pathways.\n\nIt is related to several cancers. The oncogenic effect of TRIM59 on tumor proliferation and migration has been studied in various cancers, including gastric cancer, osteosarcoma, lung and CRC. The biological activity of TRIM59 has been observed to be closely associated with the regulation of P53. TRIM59 interacts with P53, leading to P53 ubiquitination and degradation, and consequently promotes tumor growth and migration. TRIM59 functions as an oncogene in CRC progression. It also activates the PI3K/AKT pathway. Increased activity of this pathway is often associated with tumor progression and resistance to cancer therapies. AKT can control TIGAR protein translation by activation of mTOR.\n\nTargeting TRIM59 inhibition will inhibit PI3K-Akt pathway downregulate TIGAR protein translation. This is in turn downregulates GSH levels, increases ROS production, leading to cell death and blocks the cellular proliferation and survival of cancer cells leading to tumor regression. Therefore, TRIM59 protein can serve as a new potential therapeutic target for CRC."
            },
            "ConditionsModule": {
                "ConditionList": {
                    "Condition": [
                        "Colorectal Cancer"
                    ]
                },
                "KeywordList": {
                    "Keyword": [
                        "colorectal cancer",
                        "TIGAR",
                        "TRIM59"
                    ]
                }
            },
            "DesignModule": {
                "StudyType": "Observational",
                "PatientRegistry": "No",
                "DesignInfo": {
                    "DesignObservationalModelList": {
                        "DesignObservationalModel": [
                            "Case-Control"
                        ]
                    },
                    "DesignTimePerspectiveList": {
                        "DesignTimePerspective": [
                            "Prospective"
                        ]
                    }
                },
                "BioSpec": {
                    "BioSpecRetention": "Samples With DNA",
                    "BioSpecDescription": "tumor tissue samples and normal intestinal tissue samples from the safety margin around the tumor"
                },
                "EnrollmentInfo": {
                    "EnrollmentCount": "180",
                    "EnrollmentType": "Actual"
                }
            },
            "ArmsInterventionsModule": {
                "ArmGroupList": {
                    "ArmGroup": [
                        {
                            "ArmGroupLabel": "Colorectal cancer patients",
                            "ArmGroupDescription": "50 Patients confirmed histopathologically to have early stages of colorectal cancer.",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Genetic: Markers in tissue samples: (TIGAR , TRIM59, P53, AKT, GSH)"
                                ]
                            }
                        },
                        {
                            "ArmGroupLabel": "Risky group",
                            "ArmGroupDescription": "20 risky patients (those with ulcerative colitis, chron's disease, familial adenomatous polyposis).",
                            "ArmGroupInterventionList": {
                                "ArmGroupInterventionName": [
                                    "Genetic: Markers in tissue samples: (TIGAR , TRIM59, P53, AKT, GSH)"
                                ]
                            }
                        }
                    ]
                },
                "InterventionList": {
                    "Intervention": [
                        {
                            "InterventionType": "Genetic",
                            "InterventionName": "Markers in tissue samples: (TIGAR , TRIM59, P53, AKT, GSH)",
                            "InterventionDescription": "The followings markers will be investigated in tissue samples:\n\nTIGAR expression using quantitative real-time polymerase chain reaction (q Rt PCR) and immunohistochemistry.\nTRIM59 expression using quantitative real-time polymerase chain reaction (q Rt PCR) and immunohistochemistry.\n\nP53 expression using immunohistochemistry. P53 nuclear localization is essential for its normal function in growth inhibition or induction of apoptosis.\n\nAkt expression using western blot.\nGSH using chemical methods.",
                            "InterventionArmGroupLabelList": {
                                "InterventionArmGroupLabel": [
                                    "Colorectal cancer patients",
                                    "Risky group"
                                ]
                            }
                        }
                    ]
                }
            },
            "OutcomesModule": {
                "PrimaryOutcomeList": {
                    "PrimaryOutcome": [
                        {
                            "PrimaryOutcomeMeasure": "Measure TIGAR in the study groups.",
                            "PrimaryOutcomeDescription": "Measure TIGAR expression in colorectal cancer patients and risky group patients.",
                            "PrimaryOutcomeTimeFrame": "1 YEAR"
                        },
                        {
                            "PrimaryOutcomeMeasure": "Measure TRIM59 in the study groups.",
                            "PrimaryOutcomeDescription": "Measure TRIM59 expression in colorectal cancer patients and risky group patients.",
                            "PrimaryOutcomeTimeFrame": "1Year"
                        }
                    ]
                },
                "SecondaryOutcomeList": {
                    "SecondaryOutcome": [
                        {
                            "SecondaryOutcomeMeasure": "Targeting new prognostic and therapeutic markers for colorectal cancer.",
                            "SecondaryOutcomeDescription": "Finding a relationship between TIGAR and TRIM 59 expression and PI3K/AKT pathway as a major signaling mechanism in tumorigenesis for targeting new prognostic and therapeutic markers for colorectal cancer.",
                            "SecondaryOutcomeTimeFrame": "1 year"
                        }
                    ]
                }
            },
            "EligibilityModule": {
                "EligibilityCriteria": "Inclusion Criteria:\n\nAll Patients confirmed histopathologically to have early stages of colorectal cancer.\nRisky group patients (including those with ulcerative colitis, chron's disease, familial adenomatous polyposis).\n\nExclusion Criteria:\n\nPatients with previous history of CRC treated with chemotherapy or presence of other types of cancer.",
                "HealthyVolunteers": "No",
                "Gender": "All",
                "StdAgeList": {
                    "StdAge": [
                        "Child",
                        "Adult",
                        "Older Adult"
                    ]
                },
                "StudyPopulation": "All Patients confirmed histopathologically to have early stages of colorectal cancer admitted to General Surgery Department -Assiut University Hospital for CRC resection.\nRisky group patients (including those with ulcerative colitis, chron's disease, familial adenomatous polyposis) undergoing diagnostic colonoscopy.",
                "SamplingMethod": "Non-Probability Sample"
            },
            "ContactsLocationsModule": {
                "OverallOfficialList": {
                    "OverallOfficial": [
                        {
                            "OverallOfficialName": "Asmaa Alaaeldeen Kamal, MD (PhD student)",
                            "OverallOfficialAffiliation": "Assiut University",
                            "OverallOfficialRole": "Principal Investigator"
                        },
                        {
                            "OverallOfficialName": "Ragaa Hamdy Salama, Professor (MD)",
                            "OverallOfficialAffiliation": "Assiut University",
                            "OverallOfficialRole": "Study Director"
                        },
                        {
                            "OverallOfficialName": "Maha Ali Essam al-Din, lecturer (MD)",
                            "OverallOfficialAffiliation": "Assiut University",
                            "OverallOfficialRole": "Study Director"
                        },
                        {
                            "OverallOfficialName": "Marwa AbdelHafiz Abdel Hassan, lecturer (MD)",
                            "OverallOfficialAffiliation": "Assiut University",
                            "OverallOfficialRole": "Study Director"
                        },
                        {
                            "OverallOfficialName": "Ahmed Ali Abdel Motelb, lecturer (MD)",
                            "OverallOfficialAffiliation": "Assiut University",
                            "OverallOfficialRole": "Study Director"
                        }
                    ]
                },
                "LocationList": {
                    "Location": [
                        {
                            "LocationFacility": "Assiut University- faculty of medicine -Medical biochemistry department",
                            "LocationCity": "Assiut",
                            "LocationZip": "71111",
                            "LocationCountry": "Egypt"
                        }
                    ]
                }
            },
            "ReferencesModule": {
                "ReferenceList": {
                    "Reference": [
                        {
                            "ReferencePMID": "28052033",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Yang J, Wen J, Tian T, Lu Z, Wang Y, Wang Z, Wang X, Yang Y. GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer. Oncotarget. 2017 Feb 14;8(7):11788-11796. doi: 10.18632/oncotarget.14352."
                        },
                        {
                            "ReferencePMID": "23726973",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Cheung EC, Athineos D, Lee P, Ridgway RA, Lambie W, Nixon C, Strathdee D, Blyth K, Sansom OJ, Vousden KH. TIGAR is required for efficient intestinal regeneration and tumorigenesis. Dev Cell. 2013 Jun 10;25(5):463-77. doi: 10.1016/j.devcel.2013.05.001. Epub 2013 May 30."
                        },
                        {
                            "ReferencePMID": "21820150",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Won KY, Lim SJ, Kim GY, Kim YW, Han SA, Song JY, Lee DK. Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. Hum Pathol. 2012 Feb;43(2):221-8. doi: 10.1016/j.humpath.2011.04.021. Epub 2011 Aug 4."
                        },
                        {
                            "ReferencePMID": "26691054",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Zhao M, Fan J, Liu Y, Yu Y, Xu J, Wen Q, Zhang J, Fu S, Wang B, Xiang L, Feng J, Wu J, Yang L. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-kappaB pathway modulation. Int J Oncol. 2016 Feb;48(2):756-64. doi: 10.3892/ijo.2015.3297. Epub 2015 Dec 17."
                        },
                        {
                            "ReferencePMID": "25046164",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH, Gao WQ. TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53. Gastroenterology. 2014 Nov;147(5):1043-54. doi: 10.1053/j.gastro.2014.07.021. Epub 2014 Jul 18."
                        },
                        {
                            "ReferencePMID": "27121462",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Liang J, Xing D, Li Z, Shen J, Zhao H, Li S. TRIM59 is upregulated and promotes cell proliferation and migration in human osteosarcoma. Mol Med Rep. 2016 Jun;13(6):5200-6. doi: 10.3892/mmr.2016.5183. Epub 2016 Apr 25."
                        },
                        {
                            "ReferencePMID": "26599082",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Zhan W, Han T, Zhang C, Xie C, Gan M, Deng K, Fu M, Wang JB. TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins. PLoS One. 2015 Nov 24;10(11):e0142596. doi: 10.1371/journal.pone.0142596. eCollection 2015."
                        },
                        {
                            "ReferencePMID": "28534983",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Sun Y, Ji B, Feng Y, Zhang Y, Ji D, Zhu C, Wang S, Zhang C, Zhang D, Sun Y. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway. Oncol Rep. 2017 Jul;38(1):43-52. doi: 10.3892/or.2017.5654. Epub 2017 May 22."
                        },
                        {
                            "ReferencePMID": "28153010",
                            "ReferenceType": "background",
                            "ReferenceCitation": "Ahmad R, Alam M, Hasegawa M, Uchida Y, Al-Obaid O, Kharbanda S, Kufe D. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer. Mol Cancer. 2017 Feb 2;16(1):33. doi: 10.1186/s12943-017-0608-9."
                        }
                    ]
                }
            },
            "IPDSharingStatementModule": {
                "IPDSharing": "Undecided"
            }
        },
        "DerivedSection": {
            "MiscInfoModule": {
                "VersionHolder": "September 08, 2023"
            },
            "ConditionBrowseModule": {
                "ConditionMeshList": {
                    "ConditionMesh": [
                        {
                            "ConditionMeshId": "D000015179",
                            "ConditionMeshTerm": "Colorectal Neoplasms"
                        }
                    ]
                },
                "ConditionAncestorList": {
                    "ConditionAncestor": [
                        {
                            "ConditionAncestorId": "D000007414",
                            "ConditionAncestorTerm": "Intestinal Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000005770",
                            "ConditionAncestorTerm": "Gastrointestinal Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000004067",
                            "ConditionAncestorTerm": "Digestive System Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000009371",
                            "ConditionAncestorTerm": "Neoplasms by Site"
                        },
                        {
                            "ConditionAncestorId": "D000009369",
                            "ConditionAncestorTerm": "Neoplasms"
                        },
                        {
                            "ConditionAncestorId": "D000004066",
                            "ConditionAncestorTerm": "Digestive System Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000005767",
                            "ConditionAncestorTerm": "Gastrointestinal Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000003108",
                            "ConditionAncestorTerm": "Colonic Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000007410",
                            "ConditionAncestorTerm": "Intestinal Diseases"
                        },
                        {
                            "ConditionAncestorId": "D000012002",
                            "ConditionAncestorTerm": "Rectal Diseases"
                        }
                    ]
                },
                "ConditionBrowseLeafList": {
                    "ConditionBrowseLeaf": [
                        {
                            "ConditionBrowseLeafId": "M17580",
                            "ConditionBrowseLeafName": "Colorectal Neoplasms",
                            "ConditionBrowseLeafAsFound": "Colorectal Cancer",
                            "ConditionBrowseLeafRelevance": "high"
                        },
                        {
                            "ConditionBrowseLeafId": "M10138",
                            "ConditionBrowseLeafName": "Intestinal Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8576",
                            "ConditionBrowseLeafName": "Gastrointestinal Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6946",
                            "ConditionBrowseLeafName": "Digestive System Neoplasms",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6945",
                            "ConditionBrowseLeafName": "Digestive System Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M8573",
                            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M6026",
                            "ConditionBrowseLeafName": "Colonic Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M10134",
                            "ConditionBrowseLeafName": "Intestinal Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        },
                        {
                            "ConditionBrowseLeafId": "M14534",
                            "ConditionBrowseLeafName": "Rectal Diseases",
                            "ConditionBrowseLeafRelevance": "low"
                        }
                    ]
                },
                "ConditionBrowseBranchList": {
                    "ConditionBrowseBranch": [
                        {
                            "ConditionBrowseBranchAbbrev": "BC04",
                            "ConditionBrowseBranchName": "Neoplasms"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "BC06",
                            "ConditionBrowseBranchName": "Digestive System Diseases"
                        },
                        {
                            "ConditionBrowseBranchAbbrev": "All",
                            "ConditionBrowseBranchName": "All Conditions"
                        }
                    ]
                }
            }
        }
    }
}